Hybrid Versus Catheter Ablation for Persistent Atrial Fibrillation and Heart Failure: The HALT AF Randomised Trial

29 August 2026 (13:45 - 14:00)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Omar Ahmed

St George's Hospital (London), London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Pulmonary Vein Isolation with Pulsed Field Ablation with versus without Posterior Wall Ablation in Patients with Symptomatic Persistent Atrial Fibrillation

Professor L. Roten (Bern, CH)

Presentation thumbnail

Pulsed-Field Ablation With/Without Electrogram Mapping of Key Substrates for Non-paroxysmal Atrial Fibrillation: A Prospective Multicenter Randomized Study (PEAK-AF Study)

Doctor K. Li (Shanghai, CN)

Presentation thumbnail

12-month safety and effectiveness of a dual energy focal pulsed field ablation system to treat paroxysmal atrial fibrillation: results from the FlexPulse IDE study

Doctor A. Hussein (Cleveland, US)

Presentation thumbnail

AI-Guided Shared Decision-Making for Optimizing Patient Selection in Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial (AI-PAFA Trial)

Doctor T. Hwang (Seoul, KR)

Access the full session

Session thumbnail

The evolution of atrial fibrillation ablation: energy, mapping and precision patient selection

The Event

Event poster

ESC Congress 2026

29 August 2026 13:45 CET

You may be interested in

Congress Presentation

Hybrid AF ablation: EP meets the surgeon

8 April 2024

Congress Session

HOT LINE 8

30 August 2026

Congress Session

Late Breaking Science - Day 2

17 April 2023

Congress Session

Late-Breaking Science: persistent atrial fibrillation ablation

13 April 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources